Document Detail


Update on the European Vasculitis Study Group trials.
MedLine Citation:
PMID:  11148715     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Over the last fifteen years, collaborative vasculitis studies in Europe have established the association of antineutrophil cytoplasmic antibodies (ANCA) with vasculitis and defined its clinical role as a diagnostic tool. More recently, the European Vasculitis Study Group has developed a consensus approach to the treatment of vasculitis and has aimed to harmonize and optimize current therapy by a series of multicenter randomized controlled trials. The first trial to report, CYClophosphamide or AZathioprine As a REMission therapy for vasculitis (CYCAZAREM), demonstrated that, for generalized vasculitis, azathioprine is as effective as continued cyclophosphamide for the maintenance of remission. Other trials are investigating the roles of methotrexate, plasma exchange, and pulse cyclophosphamide in acute disease, and strategies to prevent relapse over the longer term. Parallel studies are determining prognostic markers, evaluating tools for monitoring disease, and examining the association of ANCA and infection with relapse. The established infrastructure and accumulated database are well placed to facilitate testing of newer therapeutic strategies in the future.
Authors:
D Jayne
Related Documents :
1561285 - Prodromal symptoms and signs of bipolar relapse: a report based on prospectively collec...
24277675 - Depression and quality of life in youth-onset type 2 diabetes mellitus.
19288975 - Riluzole for relapse prevention following intravenous ketamine in treatment-resistant d...
24762315 - Evaluating improvement.
11129665 - Is dosage of physiotherapy a critical factor in deciding patterns of recovery from stro...
9455935 - Burden of illness, metabolic control, and complications in relation to depressive sympt...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in rheumatology     Volume:  13     ISSN:  1040-8711     ISO Abbreviation:  Curr Opin Rheumatol     Publication Date:  2001 Jan 
Date Detail:
Created Date:  2001-01-26     Completed Date:  2001-02-22     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9000851     Medline TA:  Curr Opin Rheumatol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  48-55     Citation Subset:  IM    
Affiliation:
Senior Lecturer in Renal Medicine, Renal Unit, St. Helier Hospital, Carshalton, Surrey, UK. djayne@sghms.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clinical Trials as Topic / statistics & numerical data*
Europe
Humans
Multicenter Studies as Topic / statistics & numerical data*
Vasculitis / drug therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Magnetic resonance imaging of large vessel vasculitis.
Next Document:  Eosinophilia and musculoskeletal disease.